Skip to content
10-K

Annual Report

TransMedics Group, Inc. TMDX

0000950170-25-029104

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 31, 2025 33.66M sh
Current Liabilities FY 2024 · Dec 31, 2023 $54.93M
Total Liabilities FY 2024 · Dec 31, 2023 $568.85M
Current Assets FY 2024 · Dec 31, 2023 $510.65M
Total Assets FY 2024 · Dec 31, 2023 $706.05M
Shares Diluted FY 2024 · Dec 31, 2022 29.56M sh
Capex FY 2024 · Dec 31, 2022 $11.91M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$45.82M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.23
Eps Basic FY 2024 · Dec 31, 2022 −$1.23
Sga Expense FY 2024 · Dec 31, 2022 $69.9M
Rd Expense FY 2024 · Dec 31, 2022 $26.81M
Net Income FY 2024 · Dec 31, 2022 −$36.23M
Operating Income FY 2024 · Dec 31, 2022 −$31.44M
Gross Profit FY 2024 · Dec 31, 2022 $65.27M
Cost Of Revenue FY 2024 · Dec 31, 2022 $28.19M
Stockholders Equity FY 2024 · Dec 31, 2021 $67.85M